Original language | English |
---|---|
Pages (from-to) | 328-330 |
Number of pages | 3 |
Journal | Ophthalmology |
Volume | 128 |
Issue number | 2 |
Early online date | 08 Jul 2020 |
DOIs | |
Publication status | Published - 01 Feb 2021 |
Bibliographical note
Funding Information:P.S.W.: Consultant ? Boehringer Ingelheim, Novartis Pharma GmbH; Financial support ? Boehringer Ingelheim, Philips Medical Systems, Sanofi-Aventis, Bayer Vital, Daiichy Sankyo, DiaSorin, I.E.M., Bayer AG, Novartis Pharma GmbH; Lecturer ? Sanofi-Aventis, Bayer Vital, Daiichy Sankyo, Bayer Health Care, Astra Zeneca, DiaSorin, Bayer AGThe Gutenberg Health Study is funded through the government of Rhineland-Palatinate (?Stiftung Rheinland-Pfalz f?r Innovation,? contract no.: AZ 961-386261/733); the Johannes Gutenberg-University of Mainz, Mainz, Germany (research programs ?Wissenschafft-Zukunft? and ?Center for Translational Vascular Biology?); Boehringer Ingelheim (Ingelheim, Germany); and Philips Medical Systems (Hamburg, Germany). Further support (A.K.S.) from ?Stiftung Auge?, financed by ?Deutsche Ophthalmologische Gesellschaft? and ?Berufsverband der Augen?rzte Deutschlands e.V.? (endowed professorship for ophthalmic healthcare research); the Federal Ministry of Education and Research (grant no.: BMBF 01E01503 [P.S.W.]); and the German Center for Cardiovascular Research (P.S.W.). The sponsors and funding organizations had no role in the design or conduct of this research.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
ASJC Scopus subject areas
- Ophthalmology